Q32 Bio, Inc. (QTTB)
8.02
-0.72
(-8.24%)
USD |
NASDAQ |
Oct 13, 13:16
Q32 Bio Total Return Level : 8.74 for Oct. 12, 2026
Total Return Level Chart
Historical Total Return Level Data
| Date | Value |
|---|---|
| October 12, 2026 | 8.74 |
| October 09, 2026 | 8.34 |
| October 08, 2026 | 8.09 |
| October 07, 2026 | 7.99 |
| October 06, 2026 | 8.11 |
| October 05, 2026 | 8.37 |
| October 02, 2026 | 8.23 |
| October 01, 2026 | 8.25 |
| September 30, 2026 | 8.27 |
| September 29, 2026 | 9.53 |
| September 28, 2026 | 9.23 |
| September 25, 2026 | 8.77 |
| September 24, 2026 | 9.22 |
| September 23, 2026 | 9.56 |
| September 22, 2026 | 10.57 |
| September 21, 2026 | 10.47 |
| September 18, 2026 | 10.54 |
| September 17, 2026 | 10.86 |
| September 16, 2026 | 10.98 |
| September 15, 2026 | 11.17 |
| September 14, 2026 | 10.91 |
| September 11, 2026 | 11.10 |
| September 10, 2026 | 10.72 |
| September 09, 2026 | 11.14 |
| September 08, 2026 | 11.69 |
| Date | Value |
|---|---|
| September 04, 2026 | 11.99 |
| September 03, 2026 | 12.80 |
| September 02, 2026 | 13.59 |
| September 01, 2026 | 14.36 |
| August 31, 2026 | 14.87 |
| August 28, 2026 | 15.03 |
| August 27, 2026 | 16.15 |
| August 26, 2026 | 16.18 |
| August 25, 2026 | 16.32 |
| August 24, 2026 | 16.36 |
| August 21, 2026 | 15.97 |
| August 20, 2026 | 15.86 |
| August 19, 2026 | 15.84 |
| August 18, 2026 | 15.29 |
| August 17, 2026 | 15.95 |
| August 14, 2026 | 15.15 |
| August 13, 2026 | 15.37 |
| August 12, 2026 | 15.37 |
| August 11, 2026 | 15.41 |
| August 10, 2026 | 15.67 |
| August 07, 2026 | 15.60 |
| August 06, 2026 | 16.20 |
| August 05, 2026 | 16.49 |
| August 04, 2026 | 16.16 |
| August 03, 2026 | 15.16 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Return Level Benchmarks
| Intellia Therapeutics, Inc. | 12.58 |
| Beam Therapeutics, Inc. | 25.13 |
| Prime Medicine, Inc. | 3.61 |
| Prelude Therapeutics, Inc. | 3.74 |
| Twist Bioscience Corp. | 151.86 |